1Read EJ, Carter CS, Khuu HM, Taylor L, Taga TM. Evaluation of a closed automated system to isolate PBMC for DC immunotherapy. Cytotherapy. 2003;5(5,Suppl):456.
2
Powell DJ, Brennan AL, Zheng Z, Huynh H, Cotte J, Levine BL. Efficient clinical-scale enrichment of lymphocytes for use in adoptive immunotherapy using a modified counterflow centrifugal elutriation program. Cytotherapy. 2009.11(7):923-935.
✝Typical results based on cell counts from a leukapheresis product collected the previous day from normal donors on a COBE® Spectra Apheresis System. 80 mL to 230 mL products contained 5 to 14 × 109 WBC count, 80 percent to 100 percent mononuclear cell and 1.8 mL to 4.7 mL red blood cell volume.
*Customers are responsible for validating the use of the Elutra system to separate cells for their intended therapy.